Your browser doesn't support javascript.
loading
The Effect of Terlipressin on Renal Replacement Therapy in Patients with Hepatorenal Syndrome.
Velez, Juan Carlos Q; Wong, Florence; Reddy, K Rajender; Sanyal, Arun J; Vargas, Hugo E; Curry, Michael P; Gonzalez, Stevan A; Pappas, S Chris; Jamil, Khurram.
Affiliation
  • Velez JCQ; Department of Nephrology, Ochsner Health, New Orleans, Louisiana.
  • Wong F; Ochsner Clinical School, The University of Queensland, Brisbane, Queensland, Australia.
  • Reddy KR; Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
  • Sanyal AJ; Division of Gastroenterology and Hepatology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania.
  • Vargas HE; Division of Gastroenterology, Hepatology and Nutrition, Department of Internal Medicine, Virginia Commonwealth University, Richmond, Virginia.
  • Curry MP; Division of Gastroenterology and Hepatology, Mayo Clinic, Phoenix, Arizona.
  • Gonzalez SA; Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts.
  • Pappas SC; Department of Medicine, Baylor Scott & White All Saints Medical Center, Fort Worth, Texas.
  • Jamil K; Orphan Therapeutics LLC, Longboat Key, Florida.
Kidney360 ; 4(8): 1030-1038, 2023 08 01.
Article in En | MEDLINE | ID: mdl-37143199

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hepatorenal Syndrome / Continuous Renal Replacement Therapy Type of study: Clinical_trials / Prognostic_studies Limits: Humans Language: En Journal: Kidney360 Year: 2023 Type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hepatorenal Syndrome / Continuous Renal Replacement Therapy Type of study: Clinical_trials / Prognostic_studies Limits: Humans Language: En Journal: Kidney360 Year: 2023 Type: Article